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Abstract
Relaxin (RLN) is a key hormone of pregnancy in mammals best known for its involvement in connective tissue remodeling. In the 
domestic dog, placental RLN is the only known endocrine marker of pregnancy. However, knowledge is sparse regarding the 
spatio-temporal expression of RLN and its receptors (RXFP1 and RXFP2) in the canine uterus and placenta. Here, their expression was 
investigated in the pre-implantation uterus and utero-placental compartments (UtPl) at selected time points during gestation: 
post-implantation, mid-gestation, and at normal and antigestagen-induced luteolysis/abortion. Immunohistochemistry with newly 
generated, canine-specific antisera, in situ hybridization and semi-quantitative PCR were applied. In compartmentalization studies, 
placental and endometrial RLN increased continuously toward prepartum. The placental RXFP1 was time-related and highest during 
post-implantation and decreased together with RXFP2 at prepartum luteolysis. The endometrial levels of both receptors did not vary 
greatly, but myometrial RXFP2 decreased from mid-gestation to prepartum luteolysis. Antigestagen treatment resulted in suppression 
of RLN in UtPl and decreased RXFP1 and RXFP2 in the uterus. The placental RLN was localized mainly in the cytotrophoblast. 
Additionally, RXFP1 stained strongly in placental endothelial cells while RXFP2 was found mainly in maternal decidual cells. Uterine 
staining for all targets was found in epithelial cellular constituents and in myometrium. Finally, besides its endocrine functions, RLN 
seems to be involved in auto-/paracrine regulation of utero-placental functions in dogs in a time-dependent manner. New insights 
into feto-maternal communication was provided, in particular regarding the localization of RXFP2 in the maternal decidual cells, 
implying functional roles of RLN during the decidualization process.
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Introduction
Relaxin (RLN) is an approximately 6-kDa polypeptide 
regarded as an indispensable hormone during pregnancy 
and at parturition in many mammalian species. It 
mediates various processes during gestation and at 
parturition. Its best known function is in remodeling the 
pubic symphysis, thereby increasing its flexibility and 
facilitating the transport of fetuses at parturition (Hisaw 
1926, Zhao et al. 1999). Furthermore, e.g., in women, 
RLN was reported to promote endometrial thickening 
and vascularization, in order to facilitate early embryo 
implantation (Unemori et al. 1999). Due to its functions 
in remodeling connective tissue, RLN is also known to be 
a crucial factor involved in growth and softening of the 
uterine cervix during pregnancy (Downing & Sherwood 
1986, O’Day-Bowman et al. 1991). In several species, 
e.g., in the rat, mouse and pig, it is known to promote 
uterine quiescence (Wiqvist 1959, Griss  et  al. 1967, 
Khaligh 1968, Porter 1971, MacLennan et al. 1986). In 
addition, trophic effects of RLN were described on the 
mammary gland in pigs (Min & Sherwood 1996) and on 
the nipples in rodents (Hwang et al. 1991, Zhao et al. 
1999). There is also evidence that RLN contributes to 
pregnancy-related cardiovascular changes by affecting 
the functionality of blood vessels, heart and kidneys 
(Novak et al. 2001, Debrah et al. 2006).
As a member of a relaxin-like family, RLN is 
synthesized as a preprohormone with signal sequence 
and characteristic B–C–A structure (Sherwood 2004, 
Bathgate  et  al. 2006a). Subsequently, during post-
translational modification, the C-chain is removed 
and mature RLN consists only of the B- and A-chains. 
Although RLN shows great sequence divergence among 
species, twelve amino acids are highly conserved 
in mammals. Among these are six cysteine residues, 
which form three disulfide bonds: two inter-chain bonds 
connecting the B and A-chains, and one intra-chain 
10.1530/REP-17-0135
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bond located in the A-chain. Also, in the middle of the 
B chain, the amino acid motif Arg-X-X-X-Arg-X-X-Ile/Val 
is located, which is required for binding to receptors and 
ensuring RLN bioactivity. RLN interacts with receptors 
that belong to the family A of G-protein coupled 
receptors (GPCRs) (Bathgate  et  al. 2013). Specifically, 
RLN may bind to two receptors, RXFP1 and RXFP2. Both 
are members of the leucine-rich repeat-containing GPCR 
(LGR) subfamily that also includes receptors for follicle 
stimulating hormone (FSH) and luteinizing hormone 
(LH). It is noteworthy that both receptors are the only 
human GPCRs that possess the low-density lipoprotein 
class A (LDLa) module (Bathgate  et  al. 2006b), which 
is essential for receptor signaling. RLN binds with the 
highest affinity to RXFP1, however, it can also cross-
react with and strongly activate RXFP2 (Hsu et al. 2002).
The sources and profiles of RLN levels during 
pregnancy vary among species, and its origin does not 
coincide with the primary P4 source in many species 
(reviewed in Bathgate  et  al. 2006a). Nevertheless, 
possible direct relationships between P4 and RLN 
secretion cannot be excluded. While in some animals 
(i.e., pigs and rodents), RLN and P4 originate from 
the same tissue, i.e., corpus luteum (CL) (Anderson & 
Sherwood 1984, Anderson et al. 1984, Fields & Fields 
1985), in others, like the dog, rabbit and golden hamster 
that rely on CL as the main source of P4, RLN originates 
from the placenta (Eldridge & Fields 1985, Renegar et al. 
1987, Tsutsui & Stewart 1991). Similarly, in women 
circulating RLN is synthesized in the CL (Stoelk  et  al. 
1991). Finally, RLN can also be produced by the uterine 
endometrial glands as observed in guinea pigs (Pardo & 
Larkin 1982). Therefore, due to the variety of RLN 
effects during pregnancy, and its secretory patterns and 
physiology in different species, RLN is considered to be 
one of the most diverse, unique polypeptide hormones.
In the domestic dog (Canis lupus familiaris), luteal P4 
is required for the entire duration of gestation because 
the canine placenta lacks any steroidogenic activity 
(Hoffmann  et  al. 1994, Nishiyama  et  al. 1999); it is 
notable that the dog is the only domestic animal species 
devoid of placental steroids. Moreover, P4 profiles are 
similar in pregnant and non-pregnant cyclic bitches. 
Only shortly before parturition, around Day 60 of 
gestation, a steep decrease in P4 is observed, signaling 
the onset of active prepartum luteolysis (Concannon 
2011). Furthermore, there is no pregnancy and/or 
parturition-related elevation of E2 levels in the dog 
(Hoffmann  et  al. 1994, Onclin  et  al. 2002). Therefore, 
neither P4 nor E2 can serve as a marker of pregnancy in 
this species. Attempts to establish other reliable markers 
of pregnancy, e.g., by measurements of some acute phase 
proteins like fibrinogen or serum amyloid A, have failed 
(Vannucchi et al. 2002, Ulutas et al. 2009). Consequently, 
placental RLN is regarded, so far, as the only available 
marker of pregnancy in the dog. Originating from the 
placenta (Tsutsui & Stewart 1991), canine RLN starts to 
increase around Days 25–30 after the LH surge, peaks 
at around Day 35 of gestation and remains elevated 
until labor, after which it decreases within 1–2  days 
to undetectable levels (Steinetz  et  al. 1987, 1989, 
Gunzel-Apel  et  al. 2006). Whereas numerous studies 
investigated blood levels of RLN during canine pregnancy 
(Steinetz  et  al. 1987, 1989, Gunzel-Apel  et  al. 2006, 
Schafer-Somi et al. 2007), very little is known about the 
uterine and placental localization and expression of the 
RLN-system (i.e. RLN and its two receptors: RXFP1 and 
RXFP2) throughout canine gestation. Moreover, endocrine 
regulatory mechanisms regulating the expression and 
function of the RLN-system remain underinvestigated. 
Therefore, aiming to fill the existing knowledge gap, here 
the spatio-temporal expression and localization of RLN, 
RXFP1 and RXFP2 were investigated in the canine uterus 
and placenta at selected time points during pregnancy, 
starting with the pre-implantation period, and at normal 
and antigestagen-induced parturition. Both, RNA and 
protein expression patterns were determined, the latter 
using canine-specific, custom-made antibodies.
Materials and methods
Tissue collection and preservation
Tissue materials from healthy, crossbreed bitches, aged 
2–8 years, were collected by ovariohysterectomy (OHE). The 
samples included utero-placental compartments (UtPl; uterus 
with adjacent placenta) and interplacental uterine sites (IntPl; 
uterine wall between attachment sites) allotted to four study 
groups, representing the following stages: pre-implantation 
(Days 8–12, n = 5), post-implantation (Days 18–25, n = 5), 
mid-gestation (Days 35–40, n = 5) and prepartum luteolysis 
(n = 3). No IntPl tissue material from prepartum luteolysis was 
available for the study. In addition, to terminate pregnancy, 
the antigestagen aglepristone (Alizine, Virbac, Bad Oldesloe, 
Germany; at a dose of 10 mg/kg bw; 2×/24 h apart) was 
administered to mid-pregnant dogs (Days 40–45 of pregnancy, 
n = 10). OHE was performed 24 h (n = 5) and 72 h (n = 5) after 
the second treatment.
For all animals, the day of mating was assigned as Day 0 
of pregnancy, and was 2–3  days after ovulation, which was 
determined by measurements of peripheral serum P4 levels 
reaching >5 ng/mL and vaginal cytology. The pre-implantation 
group was specified by the presence of embryos flushed from 
uteri. Corresponding samples from dogs negative for embryo 
flushing were used as negative controls in the comparison 
investigating effects of early embryo presence on uterine 
expression of target genes (non-pregnant group, n = 8). The 
prepartum luteolysis stage was confirmed by a decrease 
of peripheral P4 below 2–3 ng/mL in three consecutive 
measurements 6 h apart (P4 serum levels were monitored 
every 6 h starting from gestation Day 58). The corresponding 
P4 concentrations during pregnancy and at normal and 
induced luteolysis, including downregulation of the 
steroidogenic machinery at the termination of luteal function, 
were reported previously (Kowalewski  et  al. 2009, 2010). 
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All animal experiments were in accordance with animal 
welfare legislation (permits no. II 25.3-19c20-15c GI 18/14 
and VIG3-19c-20/15c GI 18,14 from Justus-Liebig University, 
Giessen, and permits no. Ankara 2006/2006 and 2008-25-124 
from Faculty of Veterinary Medicine, University of Ankara). 
Following surgery, UtPl units and IntPl samples were carefully 
separated from surrounding tissues, fixed overnight with 10% 
neutral phosphate-buffered formalin at +4°C and subsequently 
incubated with phosphate-buffered saline for 1 week, replacing 
with fresh buffer every 24 h. Afterwards, tissue material was 
dehydrated in a graded ethanol series, embedded in paraffin-
equivalent Histo-Comp (Vogel, Giessen, Germany), and finally 
used for immunohistochemistry (IHC) and non-radioactive 
in situ hybridization (ISH).
For total RNA extractions, tissue samples were placed 
in RNAlater (Ambion Biotechnology GmbH, Wiesbaden, 
Germany), using the ratio mass:volume 1:6, incubated for 24 h 
at +4°C and subsequently stored at −80°C until isolation.
Homology cloning of canine-specific relaxin/insulin-like 
family peptide receptor 1 (RXFP1) sequence
The canine-specific RXFP1 had not been characterized 
previously. Thus, prior to investigating its mRNA expression 
and localization patterns, molecular cloning and sequencing 
were performed. Using online available predicted sequences of 
canine RXFP1, three consensus pairs of primers were selected, 
designed and ordered from Microsynth AG (Balgach, CH) to 
produce overlapping cDNA products: forward-1: 5′-ACG GAT 
GGC CTT TGC AAT TT-3′; reverse-1: 5′-CCT TAA ACA CTT 
GCG GTG GA-3′; forward-2: 5′-TTG CGG TAA TTT AAC TGT 
TTT GGT-3′; reverse-2: 5′-TGC ACT TTC TGG GTC TTA AAC 
A-3′; forward-3: 5′-TGT CCA CTG AAG TAT CCG TGT-3′; 
reverse-3: 5′-GCA TCT CAC AAT ATT CTC CGT GT-3′. Hot 
start PCR was carried out using the GeneAmp Gold RNA PCR 
Kit (Applied Biosystems by Thermo Fischer) with annealing 
temperature set for 60°C in accordance with our previously 
described protocol (Kowalewski  et  al. 2006b, 2011b). Three 
overlapping amplicons encoding for canine RXFP1 were 
generated using total RNA from at least 3 utero-placental 
compartments and spanning 753, 773 and 841 bp, including 
the open reading frame; the total length of the amplified canine 
RXFP1 fragment was 2125 bp. Autoclaved water instead of 
cDNA and the so-called RT-minus control were used as 
negative controls. Following separation on 2% agarose gel 
stained with ethidium bromide, PCR products were purified 
using the QIAquick Gel Extraction Kit II (Qiagen). Next, they 
were ligated into a pGEM-T vector (Promega), transformed and 
amplified in XL1 Blue competent cells (Stratagene). Using Pure 
Yield Plasmid MiniPrep System (Promega), bacterial plasmids 
were purified and subjected to sequencing on both strands 
with T7 and SP6 primers (Microsynth). Finally, the cloned 
sequence was submitted to GenBank with the following 
accession number: KY980750.
Total RNA extraction, semi-quantitative real-time 
TaqMan PCR (qPCR) and data evaluation
The extraction of total RNA from UtPl units and IntPl sites 
was done using TRIzol reagent (Invitrogen) according to the 
manufacturer’s protocol. RNA concentrations were measured 
with a NanoDrop 2000C spectrophotometer (Thermo Fisher 
Scientific AG). RQ1 RNase-free DNase (Promega) was used for 
DNase treatment to eliminate genomic DNA contamination, 
following the supplier’s instructions. Subsequently, the 
reverse transcription (RT) reaction, using random hexamers as 
primers, was performed with reagents purchased from Applied 
Biosystems by Thermo Fisher using the previously published 
protocol (Kowalewski et al. 2006b, 2011a). For each sample, 
cDNA corresponding to 100 ng of DNase-treated total RNA 
was used per run. Reactions were carried out in an Eppendorf 
Mastercycler (Vaudaux-Eppendorf AG, Basel, Switzerland).
An automated fluorometer ABI PRISM 7500 Sequence 
Detection System (Applied Biosystems) was used for all 
semi-quantitative analyses of RLN-, RXFP1- and RXFP2-
mRNA expression in canine UtPl units, IntPl samples and in 
separately dissected utero-placental compartments from post-
implantation, mid-gestation and prepartum luteolysis groups.
For UtPl and IntPl units the 25 μL reaction mixture consisted 
of: 200 nM TaqMan Probe, 300 nM of each primer, 12.5 μL Fast 
Start Universal Probe Master (ROX) (Roche Diagnostics) and 
5 μL of cDNA corresponding to 100 ng total RNA. Duplicates 
of each sample were run in 96-well optical plates (Applied 
Biosystems). Autoclaved water and the so-called minus-RT 
controls (i.e., samples treated with DNase but not subjected to 
RT) instead of cDNA were used as negative controls.
In all qPCR experiments the conditions for amplification 
were set as follows: initial denaturation for 10 min at 95°C, 
followed by 40 cycles for 15 s at 95°C and 1 min at 60°C. The 
expression levels of target genes were normalized according to 
three reference genes: GAPDH, B-ACTIN and CYCLOPHILIN 
A and calculated using the comparative CT method (ΔΔCT 
method) according to the ABI 7500 Fast Real-Time PCR System 
protocol provided by the manufacturer and as described 
previously (Kowalewski et al. 2006b, 2011a). The efficiencies 
of the PCR assays were determined by the CT slope method 
assuring approximately 100% reaction efficiency. Based on 
the published canine CDS sequences, primers and TaqMan 
probes labeled with 6-carboxyfluorescein (6-FAM) and 
6-carboxytetramethylrhodamine (TAMRA) were designed 
with Primer Express Software ver. 2.0 (Applied Biosystems) 
and purchased from Microsynth (Balgach, Switzerland). 
Canine-specific primers and probe mixtures for B-ACTIN 
(Prod. No. Cf03023880_g1) and CYCLOPHILIN A (Prod. No. 
Cf03986523-gH) were purchased from Applied Biosystems. A 
complete list of primers and probes is provided in Table 1.
Compartmentalization of utero-placental RLN-system 
mRNA expression levels
Formalin-fixed paraffin-embedded UtPl units from post-
implantation (n = 3), mid-gestation (n = 3) and prepartum 
luteolysis (n = 3) groups were cut with a microtome (two 
sections per sample, 5 μm each) and mounted on Arcturus 
PEN Membrane Glass slides (Applied Biosystems) previously 
activated for 30 min under UV light. Subsequently, sections 
were air-dried overnight at 37°C and on the following day, 
they were deparaffinized in xylene, rehydrated in a graded, 
decreasing ethanol series, stained with hematoxylin to enable 
further morphological identification of histological tissue 
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compartments (i.e., placenta, endometrium and myometrium), 
and dried overnight at room temperature. Afterwards, using 
sterile scalpel blades, each tissue compartment was carefully 
dissected under a stereomicroscope at 50× magnification 
and transferred immediately into sterile centrifuge tubes. 
In the next step, total RNA was isolated using the RNeasy 
FFPE kit (Qiagen) following the manufacturer’s protocol. 
RNA concentrations were measured with a NanoDrop 
2000C spectrophotometer (Thermo Fisher Scientific AG) 
and covered a range from 22.1 to 207.8 ng/μL. To eliminate 
genomic DNA contamination, DNase treatment was done 
using RQ1 RNase-free DNase (Promega). Subsequently, due 
to the limited amounts of RNA, following RT-reaction with 
the High-Capacity cDNA Reverse Transcription Kit (Prod. 
No. 4368814, Applied Biosystems), cDNA pre-amplification 
was performed using the TaqMan PreAmp Master Mix Kit 
(Prod. No. 4384267, Applied Biosystems) according to 
the supplier’s protocol. Briefly, the final reaction mixture 
consisted of combined primers and probes for each target 
gene, TaqMan PreAmp Master Mix and 12.5 μL of cDNA 
that corresponded to 10 ng of RNA. Pre-amplification was 
run in an Eppendorf Mastercycler (Vaudaux-Eppendorf AG, 
Basel, Switzerland) under the following conditions: enzyme 
activation at 95°C for 10 min, 14 cycles, then 15 s at 95°C 
and 4 min at 60°C. After reaction, samples were diluted in 
the ratio of 1:20 to a final volume of 1 mL and subsequently 
used for semi-quantitative real-time PCR reactions as 
described above.
Immunohistochemistry
Since canine-specific and/or cross-reacting antibodies were not 
available commercially, canine-specific guinea pig polyclonal 
anti-RXFP1 and RXFP2, custom-made antisera were generated 
(Eurogentec, Seraing, Belgium) using the following peptide 
sequences: RXFP1: C + AELDLGSNKIENLPP-NH2, amino 
acid 217–231 and C + ATEIRNQVKKEMILA-NH2, amino acid 
532–546 of canine RXFP1 sequence with GenBank accession 
number KY980750; RXFP2: C + QTSEVRNPIGREVAV-NH2, 
amino acid 605–619 and C + LLHKHRRKSIFKTKK-NH2, 
amino acid 688–702 of canine RXFP2 sequence with 
GenBank accession number NM_001005870.1. The anti-RLN, 
canine-specific polyclonal affinity purified anti-RLN custom-
made antibody was generated in guinea pigs (Eurogentec) 
and targeted against the IPATDDKKLKAC-NH2 peptide 
sequence, amino acid 23–34 of the canine RLN sequence with 
GenBank accession number NM_001003132.1. To mimic the 
uncharged peptide bond in the protein, a NH2-terminus was 
added at the C-end of the peptide. Additionally, if needed, a 
cysteine (C+) amino acid was added at the N- or C-terminal 
position of the peptide to target the coupling site at the carrier 
protein (Eurogentec).
Immunohistochemical (IHC) staining was done using 
our previously described immunoperoxidase method 
(Kowalewski et al. 2006a,b). In brief, formalin-fixed paraffin-
embedded UtPl compartments were cut on a microtome 
(2–3 μm thick sections), mounted on SuperFrost microscope 
slides (Menzel-Glaeser, Braunschweig, Germany) and dried 
overnight at 37°C. On the following day, tissue sections 
were dewaxed in xylene, rehydrated in a graded ethanol 
series and washed for 5 min under tap water. Subsequently, 
in order to retrieve antigens, slides were placed in a plastic 
cuvette containing 10 mM citrate buffer pH 6.0 for 5 min, then 
heated for 15 min in a microwave oven set at 600 W. After 
cooling down for 20 min at ambient temperature, slides were 
rinsed under running tap water and placed on a shaker for 
30 min in 0.3% hydrogen peroxide in methanol, to quench 
endogenous peroxidase activity. Then, slides were incubated 
for 5 min in IHC buffer/0.3% Triton X, pH 7.2–7.4 (0.8 mM 
Na2HPO4, 1.47 mM KH2PO4, 2.68 mM KCl, 137 mM NaCl), 
and subsequently incubated for 20 min in 10% goat serum to 
block nonspecific binding. Finally, sections were incubated 
Table 1 List of primers and TaqMan probes used for semi-quantitative RT-PCR and for cRNA probe synthesis for in situ hybridization.
Primer Accession number Primer sequence Product length (bp)
Primers and TaqMan probes used for semi-quantitative RT-PCR
GAPDH AB028142 Forward: 5′-GCT GCC AAA TAT GAC GAC ATC A-3′ 75
Reverse: 5′-GTA GCC CAG GAT GCC TTT GAG-3′
TaqMan Probe: 5′-TCC CTC CGA TGC CTG CTT CAC TAC CTT-3′
RLN NM_001003132.1 Forward: 5′-TGC TAG GTG TCT GGC TGC TAC TAA-3′ 94
Reverse: 5′-CGG ACA TAA TCA CGA CCA CAT G-3′
TaqMan Probe: 5′-ACT TCC CAG AGA GAT CCC AGC CAC G-3′
RXFP1 KY980750 Forward: 5′-GGC ACC AAT GGA GTG TGT TTC-3′ 102
Reverse: 5′-TGC CGC CAA GTT AAC ACC AA-3′
TaqMan Probe: 5′-TAC TGG AGC CCA GAT TTA TTC GGT GGC-3′
RXFP2 NM_001005870.1 Forward: 5′-CCC TGT GGG AAT CTT ACC AAG T-3′ 98
Reverse: 5′-GTG TCA CCA CAG TTG TCC TCA TC-3′
TaqMan Probe: 5′-TTA CCC CGT GCT TTT CAC TGT GAT GGC-3′
Primers used to generate templates for probes used in in situ hybridization
RLN NM_001003132.1 Forward: 5′-GGT CGT GAT TAT GTC CGC CT-3′ 220
Reverse: 5′-ACT TCT CCT TCC CAG ACC GT-3′
RXFP1 KY980750 Forward: 5′-CTT GGT GTT AAC TTG GCG GC-3′ 241
Reverse: 5′-CCC AAG AGG TTA TGG TAC CTG G-3′
RXFP2 NM_001005870.1 Forward: 5′-CTC GTA TGC TCC CCA TGT CC-3′ 218
Reverse: 5′-GGC AGT CTG CAC AAC AAA GG-3′
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overnight with primary antibodies at the following dilutions: 
1:750 for anti-RLN antibody, 1:1000 for anti-RXFP1 and anti-
RXFP2 canine-specific antisera. To remove unbound primary 
antiserum, slides were washed with IHC buffer/0.3% Triton 
X, and incubated with biotinylated secondary, goat anti-
guinea pig antibodies (Vector Laboratories, Burlingame, CA, 
USA) at 1:100 dilution for 30 min at ambient temperature. 
After washing with IHC buffer/0.3% Triton X, in order to 
enhance signals, slides were incubated with the streptavidin-
peroxidase Vectastain ABC kit (Vector Laboratories) for 30 min 
at room temperature. Using liquid DAB+ substrate kit (Dako), 
peroxidase activity was detected. Slides were counterstained 
with hematoxylin, washed under tap water, dehydrated in a 
graded ethanol series and mounted in Histokit (Assistant, 
Osterode, Germany). For evaluating specificity of the IHC, the 
following negative controls were performed: isotype controls 
consisting of (1) either non-immunized guinea pig IgG instead 
of the primary antibody (Fig. 5I); (2) pre-immune guinea pig 
serum (Figs 6I and 7I), both at the same dilution and protein 
concentration as the primary antiserum; or (3) using primary 
antibody or antiserum pre-incubated for 2 h with immunizing 
peptides used for antibody production (blocking peptides) 
(Figs 5J, 6J and 7J).
In situ hybridization
Localization of the RLN-system in canine UtPl compartments 
was additionally evaluated at the mRNA level by employing 
a non-radioactive in situ hybridization (ISH) method as 
described previously (Kowalewski et al. 2006a, 2010). In brief, 
total RNA from UtPl units was used in RT-PCRs with canine-
specific primers for complementary RNA (cRNA) probe 
synthesis. The sequences of primers and lengths of amplicons 
are presented in Table  1. PCR products were separated on 
2% agarose gels, stained with ethidium bromide, purified 
using the QIAquick Gel Extraction Kit II (Qiagen) and ligated 
into the pGEM-T vector. Afterwards, selected clones were 
control-digested with NcoI and NotI restriction enzymes 
(New England Biolabs, Frankfurt, Germany) and submitted 
for sequencing (Microsynth). Thereafter, using the restriction 
enzymes NcoI and NotI, for sense cRNA and antisense cRNA 
respectively, plasmids were linearized and labeled with the 
DIG-RNA labeling kit (Roche Diagnostics) according to the 
manufacturer’s protocol. Dot-blot analysis of serial dilutions of 
DIG-labeled cRNA was performed on positively charged nylon 
membranes (Roche Diagnostics). To perform non-radioactive 
ISH, formalin-fixed paraffin-embedded UtPl compartments 
were cut with a microtome (2–3 μm thick sections), mounted 
on SuperFrost Plus microscope slides (Menzel-Glaeser, 
Braunschweig, Germany), dewaxed in xylene, rehydrated in 
a graded ethanol series, digested with proteinase K (70 μg/
mL; Sigma-Aldrich) for permeabilization, post-fixed with 4% 
paraformaldehyde and subjected to ISH. The hybridization was 
performed overnight at 37°C in the presence of formamide. 
Subsequently, to detect DIG-labeled cRNA, slides were 
incubated with alkaline phosphatase-conjugated sheep anti-
DIG Fab Fragments (Roche Diagnostics) used at a 1:5000 
dilution in 1% ovine serum following the manufacturer’s 
instructions. The visualization of signals was done using the 
substrate 5-bromo-4-chloro-3-indolyl phosphate and nitroblue 
tetrazolium (BCIP/NBT; Roche Diagnostics).
Figure 1 Uterine expression of the RLN-system as determined by 
real-time (TaqMan) PCR. (A) Expression of RLN, RXFP1 and RXFP2 in 
uteri of non-pregnant and early-pregnant (pre-implantation) bitches. 
(B) Expression of RLN, (C) RXFP1 and (D) RXFP2 in interplacental 
sites (IntPl) of the uterus from the pre-implantation period until 
mid-gestation. Data are presented as Xg ± s.d. Bars with different 
letters differ at P < 0.01.
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Statistics
In order to evaluate real-time (TaqMan) PCR data, statistical 
analysis was performed using the software program GraphPad 
3.06 (GraphPad Software). An unpaired, two-tailed Student’s 
t-test was performed to compare the levels of RLN and RXFP2 
in non-pregnant and pre-implantation uteri. Parametric 
one-way analysis of variance (ANOVA) was performed 
followed by a Tukey–Kramer multiple comparisons post-
test to determine the effect of time on interplacental RXFP1 
and utero-placental RLN-system mRNA expression. For 
easier presentation and interpretation of data, the latter 
analyses were performed separately with regards either to 
the compartment or to the gestation stage. Due to uneven 
distribution of the data obtained for the uterine RXFP1, 
interplacental RLN and RXFP2 mRNA expression, the Mann–
Whitney non-parametric test was performed to compare 
the RXFP1 levels in non- vs early-pregnant uteri and the 
Kruskal–Wallis test (a non-parametric ANOVA) followed by 
a Dunn’s multiple comparison test (in the event of P < 0.05) 
was done to determine the effect of time on interplacental 
RLN and RXFP2 mRNA expression at selected time points 
of pregnancy. Dunnett’s multiple comparison test was used 
to show RLN-system expression after aglepristone-induced 
luteolysis. In the latter case, the results show the n-fold change 
in each target gene mRNA compared with its expression at 
mid-gestation as a non-treated control. The numerical data 
are presented as geometric means Xg ± geometric standard 
deviation (s.d.).
Results
Expression of the RLN-system in non-pregnant and 
early-pregnant uteri and uterine expression at 
interplacental sites
First the effects of early, pre-attachment embryos on 
uterine expression of RLN and its two receptors were 
investigated. The expression of RLN and RXFP1 was 
detectable in all uterine samples from early-pregnant 
dogs and their corresponding non-pregnant controls. 
The expression of RXFP2 mRNA, which varied strongly 
among individuals, remained below the detection limit 
in 4 of 8 non-pregnant bitches. As detected by semi-
quantitative real-time PCR, the levels of all three target 
genes remained unaffected by the presence of free-
floating embryos (P > 0.05) (Fig. 1A).
In the next step, IntPl samples from post-implantation 
and mid-gestation stages were included and uterine 
expression of the RLN-system was compared during 
pre-implantation, post-implantation and mid-gestation 
stages of pregnancy (Fig.  1B, C and D). Whereas the 
uterine expression of RLN and its two receptors was 
Figure 2 Compartmentalization of RLN (A), RXFP1 (B) and RXFP2 (C) mRNA expression in canine UtPl units during pregnancy. Data are 
presented with regards to the localization of target gene expression in separate compartments at selected time points during gestation. Real-time 
(TaqMan) PCR (Xg ± s.d.) was applied. Results are presented on a logarithmic scale: ★P < 0.001, ★★P < 0.01, ★★★P < 0.05.
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detectable at all stages examined, no significant changes 
(P > 0.05) were found for RLN and RXFP1 (Fig. 1B and C). 
The mRNA levels of RXFP2 changed however, in a time-
dependent manner and decreased gradually from pre-
implantation toward mid-gestation (P < 0.01) (Fig. 1D).
Compartmentalization of utero-placental RLN-system 
expression at selected time points during pregnancy
As indicated in ‘Materials and methods’ section, data 
regarding the compartmentalization of utero-placental 
RLN-system expression throughout pregnancy are 
presented with reference either to separate compartments 
(Fig. 2) or particular gestation stage (Fig. 3).
All three members of the RLN-system were expressed 
in placenta and myometrium during selected stages of 
gestation (i.e., post-implantation, mid-gestation and 
prepartum luteolysis). Regarding endometrium, RXFP2 
was only undetectable in one animal from the post-
implantation group, possibly relating to the low mRNA 
levels obtained from the dissected compartment in that 
animal. RLN and RXFP1 were detected in all endometrial 
samples examined.
Within the compartments, placental RLN expression 
was time-dependent; it increased significantly at 
mid-gestation compared with post-implantation 
(P < 0.001), and was further elevated at prepartum 
luteolysis (P < 0.001 and P < 0.01, compared with 
post-implantation and mid-gestation respectively) 
(Fig.  2A). A similar expression pattern was observed 
for endometrial RLN expression, with a gradual but 
significant increase from post-implantation to mid-
gestation (P < 0.05), and the highest mRNA levels 
were detected at prepartum luteolysis (P < 0.001 
when compared with both post-implantation and 
mid-gestation) (Fig.  2A). Myometrial RLN levels 
remained unaffected by the stage of pregnancy 
(P = 0.29) (Fig. 2A).
The placental expression of RXFP1 revealed the 
highest abundance of transcripts during the post-
implantation period of pregnancy, followed by a 
significant decrease at mid-gestation (P < 0.001), and no 
further changes were observed at prepartum luteolysis 
(P > 0.05) (Fig.  2B). The endometrial and myometrial 
expression of RXFP1 did not change significantly 
over time (P = 0.62) (Fig.  2B). Expression patterns of 
RXFP2 were similar showing time-related changes 
within placental and myometrial compartments. 
Thus, it stayed elevated during post-implantation and 
mid-gestation stages, but decreased significantly at 
Figure 3 Compartmentalization of RLN (A), RXFP1 (B) and RXFP2 (C) mRNA expression in canine UtPl units during pregnancy. Data are 
presented with regards to the time point of gestation when the expression of target genes was investigated. Real-time (TaqMan) PCR was applied 
(Xg ± s.d.). Data are presented on a logarithmic scale: ★P < 0.001, ★★P < 0.01, ★★★P < 0.05.
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Figure 4 Antigestagen (aglepristone) effects on utero-placental (UtPl) (A, C, E) and interplacental (IntPl) (B, D, F) expression of the RLN-system 
(RLN, RXFP1 and RXFP2), as determined by real-time (TaqMan) PCR. Data are presented as Xg ± s.d. Bars with different letters differ at P < 0.01 
(A) or P < 0.05 (D, F), compared to the mid-gestation group as a non-treated control.
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Figure 5 Localization of RLN in canine uterus during pre-implantation (A, B), and in utero-placental compartments during mid-gestation (C, D, 
E) and at prepartum luteolysis (F, G, H) by immunohistochemistry using canine-specific antibody; representative pictures are shown. (A, B) 
During pre-implantation, only weak or no uterine signals are observed: solid arrows in (A) = surface (luminal) epithelium, open arrowheads in 
(A) = superficial uterine glands, open arrows in (B) = deep uterine glands, solid arrowheads in (B) = myometrium. Post-implantation and at 
prepartum luteolysis placental RLN is mostly localized in cytotrophoblast cells (open arrowheads in C and F); only weak or no signals are 
detected in syncytiotrophoblast cells (solid arrowheads in C and F) and in endothelium of maternal blood vessels (open arrows in C and F). 
Signals appear to be stronger in the placenta during prepartum luteolysis. (D, G) Endometrial signals of RLN are localized in the superficial 
uterine glands (the so-called glandular chambers) (open arrowheads in D and G); strong signals are observed also in invading trophoblast (solid 
arrows on G). (E, H) RLN signals in deep uterine glands (open arrows in E and H) and myocytes (solid arrowheads in E and H). (I, J) Negative 
controls: the specificity of staining was controlled by incubation with non-immune guinea pig IgG instead of primary antibody (isotype control, 
I) or with primary antibody pre-incubated for 2 h with peptide used for antibody production (blocking peptide, J).
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Figure 6 Localization of RXFP1 in canine uterus during pre-implantation (A, B), and in utero-placental compartments during mid-gestation (C, 
D, E) and at prepartum luteolysis (F, G, H) by immunohistochemistry using canine-specific antibodies; representative pictures are shown. (A, B) 
During pre-implantation, RXFP1 protein is strongly present in uterine epithelium (solid arrows in A) and superficial glands (open arrowheads in 
A), as well as in the deep uterine glands (open arrows in B) and myocytes (solid arrowheads in B). (C, F) Strong placental signals of RXFP1 are 
localized in maternal endothelial cells (open arrows in C and F). In particular, at prepartum luteolysis signals are also localized in 
cytotrophoblast cells (open arrowheads in F); weaker signals are localized in syncytiotrophoblast (solid arrowheads in C, F). (D, G) Endometrial 
signals of RXFP1 in the superficial uterine glands (the so-called glandular chambers) (open arrowheads in D and G); strong signals are also 
observed in invading trophoblast (solid arrows in G). (E, H) RXFP1 signals are localized in deep uterine glands (open arrows in E and H) and 
myocytes (solid arrowheads in E and H). (I, J) Negative controls: the specificity of staining was controlled by incubation with pre-immune guinea 
pig serum instead of primary antibody (isotype control, I) or with primary antiserum pre-incubated for 2 h with peptides used for antibody 
production (blocking peptides, J).
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Figure 7 Localization of RXFP2 in canine uterus during pre-implantation (A, B), and in utero-placental compartments during mid-gestation (C, 
D, E) and prepartum luteolysis (F, G, H) by immunohistochemistry using canine-specific antibodies; representative pictures are shown. (A, B) 
During pre-implantation, RXFP2 is predominantly present in uterine surface (luminal) epithelium (solid arrows in A) and superficial glands (open 
arrowheads in A), as well as in the deep uterine glands (open arrows in B) and myocytes (solid arrowheads in B). (C, F) Placental signals for 
RXFP2 are predominantly localized in maternal stroma-derived decidual cells (open arrows in C and F), occasional staining can also be 
observed in fetal fibroblasts (solid arrows in C); weaker signals are also localized in endothelium of maternal blood vessels (solid arrowheads in 
C and F). (D, G) Endometrial signals of RXFP2 in the superficial uterine glands (the so-called glandular chambers) (open arrowheads in D and 
G). (E, H) RXFP2 signals in deep uterine glands (open arrows in E and H) and myocytes (solid arrowheads in E and H). (I, J) Negative controls: 
the specificity of staining was controlled by incubation with pre-immune guinea pig serum used instead of primary antibody (isotype control, I) 
or with primary antiserum pre-incubated for 2 h with peptides used for antibody production (blocking peptides, J).
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prepartum luteolysis (P < 0.001, compared with both 
post-implantation and mid-gestation). Its endometrial 
expression did not change significantly over time 
(P = 0.15) (Fig. 2C).
Regarding gestational stages (i.e., post-implantation, 
mid-gestation and prepartum luteolysis) (Fig.  3), 
RLN was consistently highest in the placenta, followed 
by endometrium and myometrium (statistical details 
are presented in Fig.  3A). Whereas post-implantation 
placental expression of RXFP1 did not vary strongly 
(P = 0.20) between compartments (i.e., placenta, 
endometrium and myometrium), at mid-gestation 
and prepartum luteolysis its placental expression 
was significantly lower compared with endometrium 
and myometrium (P < 0.001). The myometrial and 
endometrial expression of RXFP1 did not differ 
significantly (P > 0.05) at both stages of pregnancy.
The expression of RXFP2, which did not differ 
significantly between the compartments during post-
implantation and mid-gestation stages (P = 0.42 and 
P = 0.53 respectively), was significantly more highly 
expressed in endometrium than in placenta and 
myometrium during prepartum luteolysis (P < 0.05).
The effects of antigestagen treatment on expression 
of the RLN-system in canine utero-placental units and 
interplacental sites
Antigestagen treatment was applied to mid-pregnant 
bitches and the effects on RLN, RXFP1 and RXFP2 
expression were investigated in UtPl and IntPl samples 
(Fig.  4). Corresponding samples from mid-pregnant 
bitches were used as non-treated controls in Dunnett’s 
multiple comparisons test. The expression of RLN 
decreased significantly in UtPl (P < 0.01) 72 h after the 
second treatment (Fig. 4A). However, its expression in 
IntPl did not change significantly (P = 0.15) (Fig. 4B). The 
opposite effect was observed for both RLN receptors: 
whereas their expression at IntPl was significantly 
decreased in aglepristone-treated dogs, showing 
significant effects either at 72 h (for RXFP1) or at 72 h and 
24 h (for RXFP2) after the second application (P < 0.05) 
(Fig. 4D and F), in UtPl expression levels did not change 
significantly (P = 0.42 and P = 0.81 for RXFP1 and RXFP2 
respectively) (Fig. 4C and E).
Localization of RLN, RXFP1 and RXFP2 in  
utero-placental units throughout gestation
At the protein level, localization of the utero-placental 
expression of the RLN-system was determined by IHC 
using the canine-specific custom-made antibodies 
produced against each target. No or only very weak 
signals (mostly in deep uterine glands and myometrium) 
were detected for RLN expression prior to implantation 
(Fig.  5A and B). However, following implantation 
RLN expression was clearly detectable with staining 
intensity appearing stronger during the later stages 
of pregnancy, i.e., at mid-gestation and prepartum 
luteolysis (Fig. 5C, D, E, F, G and H). Placental RLN 
was localized mainly in fetal cytotrophoblast cells; 
only weak signals were detected in syncytiotrophoblast 
and endothelium of maternal blood vessels (Fig.  5C 
and F). Additionally, RLN appeared intensively in 
invading trophoblast cells (Fig. 5G). The uterine RLN 
distribution consisted of signals located in epithelial 
compartments of superficial glands (the so-called 
glandular chambers), deep glands and in myometrium 
(Fig. 5D, E and H).
Figure 8 Localization of RLN (A), RXFP1 (B) and RXFP2 (C) mRNA in 
the canine placenta during prepartum luteolysis by in situ 
hybridization (ISH). RLN and RXFP1 signals are localized 
predominantly in the cytotrophoblast (open arrows in A and B); 
strong signals for RXFP2 mRNA are localized in the maternal 
decidual cells (open arrowheads in C); mRNA of both receptors is 
found in the endothelial cells (solid arrows in B and C). There is no 
background staining in the negative control (sense probe).
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In contrast to RLN, both RXFP1 and RXFP2 proteins 
were clearly detectable at earlier stages of pregnancy, 
namely in the pre-implantation uterus (Figs 6A, B and 
7A, B). Their expression was particularly strong in 
epithelial cellular constituents of the endometrial 
surface (luminal) epithelium and superficial and deep 
glands. Myometrial signals were clearly distinguishable 
throughout gestation, while lesser signals were 
observed in stroma. These similar uterine distribution 
patterns of both receptors were maintained following 
implantation until prepartum luteolysis (Figs 6 and 7D, 
E, G, H). However, their localization patterns differed 
in the placenta, where RXFP1 was found mostly in the 
endothelial cells throughout placentation (Fig. 6C and 
F), with some weaker signals located in fetal trophoblast 
cells (predominantly in cytotrophoblast) (Fig. 6C and F), 
whereas placental RXFP2 expression was predominantly 
localized in maternal stroma-derived decidual cells 
(Fig.  7C and F). Some fetal stromal cells occasionally 
stained for RXFP2. Further, staining for RXFP2 was also 
observed in endothelial cells of mid-pregnant placenta, 
with signals however, appearing less pronounced than 
those of RXFP1.
At the mRNA level, as detected by ISH, the localization 
patterns of RLN, RXFP1 and RXFP2 were similar to those 
signals observed for their respective protein targets 
(Fig.  8). A schematic representation of the placental 
distribution of RLN-system signals is shown in Fig. 9.
Discussion
RLN is an important hormone of pregnancy and the only 
diagnostically applicable marker of pregnancy in dogs. 
Thus, it is surprising that its expression, distribution 
and possible local functionality within the uterus and 
placenta in the dog remain largely unknown.
Therefore, our goal was to investigate the spatio-
temporal expression and localization of RLN and its 
two receptors, RXFP1 and RXFP2 (RLN-system), during 
Figure 9 Schematic representation of placental RLN-system distribution within canine utero-placental compartments (placenta 
endotheliochorialis) as determined by immunohistochemistry and in situ hybridization. From post-implantation to prepartum luteolysis RLN 
protein expression is localized mainly in cytotrophoblast cells, while weaker signals are found in syncytiotrophoblast and maternal endothelial 
cells. RXFP1 is localized predominantly in endothelial cells of maternal blood vessels. Additionally, weaker RXFP1 signals are observed in fetal 
trophoblast cells (in particular in cytotrophoblast cells at prepartum luteolysis). RXFP2 is strongly represented in maternal stroma-derived 
decidual cells and occasionally in some fetal fibroblasts. Also, maternal endothelial cells stain positively for RXFP2 however not as strongly as 
for RXFP1.
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gestation and at normal (i.e. spontaneous, prepartum) 
and antigestagen-induced luteolysis.
Here, for the first time we show the expression of the 
RLN-system in the canine pregnant uterus throughout 
pregnancy, beginning with its early pre-implantation 
stage. Whereas the local uterine expression of RLN 
appeared to be weak at the protein level, the expression 
of its receptors was clearly detectable, especially at 
the protein level, and was predominantly found in 
the endometrial epithelial components. This implies 
possible autocrine/paracrine effects of RLN in the 
canine uterus at early diestrus. At this stage however, 
these effects do not appear be pregnancy-related 
because the presence of free-floating embryos did not 
affect uterine expression of the RLN-system. Shortly after 
implantation, RLN becomes detectable in the maternal 
circulation, its secretion increases with the progression 
of placental development and it remains high until 
parturition (Tsutsui & Stewart 1991). The placentation-
associated increase in RLN coincides with our detection 
of RLN in the UtPl units, predominantly in the placenta, 
as also described elsewhere (Klonisch  et  al. 1999). 
However, as revealed in our study by applying canine-
specific anti-RLN antibody, cytotrophoblast, and not 
syncytiotrophoblast, appears to be the main provider 
of circulating RLN. Moreover, in addition to a previous 
report (Klonisch et al. 1999), although RLN expression 
remains consistently highest within the placenta, 
its endometrial expression at placentation sites also 
increases continuously throughout pregnancy. This 
has been clearly shown by the compartmentalization 
study presented herein. Its expression does not 
change, although at IntPl sites, i.e., at uterine sites not 
connected with the placenta, indicating the role of local 
interactions in regulatory mechanisms affecting RLN 
expression and possibly function at the feto-maternal 
interface. Localization of RLN was mostly associated 
with glandular epithelium, suggesting its involvement in 
endometrial secretory activity. The uterine expression of 
both receptors remained similar at IntPl and UtPl sites.
The local effects of RLN are mediated via its specific 
receptors. In addition to their strong representation 
in endometrial epithelial cells, both receptors, but 
predominantly RXFP1, were found in endothelial cells 
of maternal blood vessels. This in particular concerns 
their placental expression. RLN was reported to 
exert vasodilatatory effects, both in vivo and in  vitro, 
in systemic arterioles, capillaries and venules, 
including those present in the reproductive organs 
(Vasilenko  et  al. 1986, Lee  et  al. 1992, Longo  et  al. 
2003) and to contribute to endometrial angiogenesis 
in vivo and in vitro (Pillai  et  al. 1999, Unemori  et  al. 
1999), e.g., by stimulating the expression of vascular 
endothelial growth factor (VEGF) (Unemori et al. 1999). 
It thus appears plausible that RLN also participates in 
placental vascular system development and activity 
in the dog, by differential utilization of its receptors. 
Accordingly, apart from the similar uterine localization 
of both receptors, their cellular localization within 
the canine placenta diverged strongly. Thus, whereas 
RXFP1 was mainly co-localized with placental RLN 
in cytotrophoblast cells, RXFP2 was predominantly 
targeted to maternal decidual cells. This may be 
important, as being derived from uterine stromal cells in 
the process referred to as decidualization (Kautz et al. 
2015, Graubner  et  al. 2017), these are the only cells 
in the canine placenta bearing the nuclear P4 receptor 
(PGR). The RXFP2-mediated effects of RLN in regulating 
decidual cell function should therefore be considered. 
It is noteworthy that, apart from being one of the two 
RLN receptors, RXFP2 also acts as the main receptor 
for insulin-like 3 protein (INSL3) (Bathgate et al. 2006c). 
Whereas RLN binds to both receptors, INSL3 has only a 
low affinity for RXFP1 (Scott et al. 2012). As for female 
reproductive physiology, e.g., in cattle, the expression 
of INSL3 and its receptor RXFP2 has been implicated in 
ovarian follicular and luteal development (Satchell et al. 
2013). It thus seems that RXFP2 could play a role in 
a multifactorial regulation of utero-placental function, 
with particular regard to placental decidual cells. 
This may apply also to other species, e.g., humans, in 
which the involvement of RXFP2 in maternal decidual 
cell biology remains unclear (Hombach-Klonisch et al. 
2001). And indeed, RLN induces decidualization of 
human endometrial stromal cells in vivo by stimulating 
intracellular cAMP production (Telgmann  et  al. 1997, 
Telgmann & Gellersen 1998). Similarly, cAMP-mediated 
decidualization effects have been recently shown in 
our studies with canine uterine stromal cells in vitro 
(Kautz et al. 2015, Graubner et al. 2017).
Interestingly, concomitantly with increasing RLN 
levels, the local placental expression of both receptors 
decreases toward normal prepartum luteolysis. This 
suggests a functional shift from local to systemic 
endocrine effects of RLN during preparation for labor. 
On the other hand, RLN may exert regulatory feedback 
effects on the expression of its receptors, thereby 
coordinating its own local bioavailability.
Regarding the myometrium, RLN and RXFP1 levels did 
not change over time however RXFP2 levels decreased 
at prepartum luteolysis. In particular, the consistently 
strong presence of myometrial RXFP1 implies RLN-
mediated involvement in growth and development of 
the uterus and, possibly, in sustaining uterine quiescence 
during pregnancy, as shown previously in vitro in pigs 
and rodents (Griss et al. 1967, MacLennan et al. 1986). 
The latter hypothesis needs to be verified for the dog 
in which possible involvement of RLN in myometrial 
contractility remains unknown. If they exist in dogs, 
these effects could be of rather a secondary nature by 
preventing the uterus from spontaneous contractions, 
while physiological myometrial contractility still occurs 
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when plasma RLN is elevated and RXFP1 is available in 
the myometrium.
Interfering with P4 function at the level of PGR by 
administering its antagonist aglepristone initiates the 
luteolytic cascade in the dog and results in prepartum 
PGF2α release (Kowalewski et al. 2010). The latter must 
originate in fetal trophoblast cells where the enzymatic 
machinery responsible for prostaglandin synthesis is 
strongly active (Kowalewski  et  al. 2010). Contrasting 
with normal prepartum luteolysis, in this study, after 
functional withdrawal of P4, we observed suppression 
of RLN expression in UtPl but not in IntPl sites, 
indicating this decrease to be related to placental RLN 
synthesis. Thus, RLN expression was suppressed 24 h 
after the second treatment with aglepristone and was 
further significantly decreased at 72 h. Both receptors 
were negatively affected by the treatment at IntPl sites. 
All antigestagen-mediated effects were associated 
with strong individual variations in gene expression. 
Our observations are in agreement with previously 
reported data showing decreased blood levels of 
RLN in dogs with aglepristone-induced abortions 
(Gunzel-Apel  et  al.  2009). It seemed however, to be 
an effect of placental disintegration that led to the RLN 
decrease, rather than a rapid reaction to P4 withdrawal, 
because no immediate treatment-related changes in RLN 
secretion patterns were observed in that study. In another 
study (Schafer-Somi  et  al. 2007) in dogs treated with 
aglepristone at Day 30 of pregnancy, RLN levels were 
not altered during abortion but decreased continuously 
thereafter. In both of those studies, circulating RLN varied 
strongly among individuals upon aglepristone treatment. 
The effects exerted by antigestagen on utero-placental 
RLN secretion thus seem, at least in part, to be linked 
to individual responsiveness to the luteolytic insult and 
the time of pregnancy when the treatment was applied. 
Progesterone however, does not seem to be directly 
involved in regulating utero-placental RLN synthesis in 
the dog. While RLN does not seem to be involved in the 
initiation of labor, there are several pieces of evidence 
that it affects the duration of parturition (Nara et al. 1982, 
Downing & Sherwood 1985, Burger & Sherwood 1995). 
Therefore, the RLN decrease after administering a PGR 
antagonist at gestational stages when fetal resorption is 
not possible any more could potentially result in slower 
passage of pups through the birth canal and an extended 
total duration of the abortion.
In conclusion, by showing the uterine and placental 
expression of the RLN-system during gestation, and 
especially by demonstrating changes occurring during 
parturition, here new insights into the physiology of 
canine pregnancy are provided. Custom-made canine-
specific antibodies were generated that allowed us 
to investigate the cellular localization of the RLN-
system within the canine uterus and placenta. In 
this way, evidence has been provided that within the 
canine placenta, cytotrophoblast is the main source 
of circulating RLN (summarized in schematic Fig.  9). 
Additionally, the basic synthetic capability of canine 
uterus to produce RLN has been shown. Moreover, 
by establishing RXFP1 and RXFP2 expression and 
localization, we can conclude that RLN targets are 
widespread in canine reproductive tissues and include 
both fetal and maternal parts of the placenta, as well 
as endothelium of placental blood vessels and uterus. 
Acting locally in the uterus and placenta, RLN may act 
also in an autocrine and paracrine manner. Thus, besides 
being involved in preparation for parturition, it seems 
to exert other, e.g., angiogenic and secretory, effects. 
Furthermore, a new interesting aspect of feto-maternal 
communication in the dog has been brought to light by 
revealing the spatial distribution of RLN receptors. This in 
particular concerns the maternal decidual cell-targeted 
expression of RXFP2, strongly implying functional roles 
of RLN during the decidualization process and thereby 
determining one of our future study directions. From the 
practical point of view, the opposing patterns of RLN 
expression during natural and antigestagen-induced 
luteolysis clearly indicate differences in endocrine and 
cell-biological mechanisms existing between natural 
labor and antigen-induced abortion, which may have 
clinical implications.
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